RECRUITING

Implementing a Randomized Control Trial to Test the Expanded Web-based Decision Aid

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The overall goal of the randomized control trial (RCT) will be to evaluate the efficacy of modifications to a web-based tool for patient decision-making regarding return of genomic results that will more closely focus on rare cancers. Participants will be given access to a web-based decision aid (or a standard control) that guides participants in making decisions about what type of genomic results they would like to receive from testing performed in the PE-CGS study (NCT06340646).

Official Title

Implementing a Randomized Control Trial to Test the Expanded Web-based Decision Aid

Quick Facts

Study Start:2025-04-30
Study Completion:2026-09-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06910670

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Erin Linnenbringer, Ph.D., MS
CONTACT
314-747-1966
elinnen@wustl.edu
Bettina Drake, Ph.D., MPH
CONTACT
314-747-4534
drakeb@wustl.edu

Principal Investigator

Erin Linnenbringer, Ph.D., MS
PRINCIPAL_INVESTIGATOR
Washington University School of Medicine

Study Locations (Sites)

Washington University School of Medicine
Saint Louis, Missouri, 63110
United States

Collaborators and Investigators

Sponsor: Washington University School of Medicine

  • Erin Linnenbringer, Ph.D., MS, PRINCIPAL_INVESTIGATOR, Washington University School of Medicine

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-04-30
Study Completion Date2026-09-30

Study Record Updates

Study Start Date2025-04-30
Study Completion Date2026-09-30

Terms related to this study

Keywords Provided by Researchers

  • Genetic testing
  • Decision aid
  • Participant engagement

Additional Relevant MeSH Terms

  • Cholangiocarcinoma
  • Colorectal Cancer
  • Multiple Myeloma